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 The discovery of the zDHHC family of S-acyltransferase enzymes has been one of the major 
breakthroughs in the S-acylation field. Now, more than a decade since their discovery, major 
questions centre on profiling the substrates of individual zDHHC enzymes (there are twenty-four 
ZDHHC genes and several hundred S-acylated proteins), defining the mechanisms of enzyme-





 The post-translational modification of cellular proteins by S-acylation, the reversible 
attachment of fatty acids onto cysteine residues, mediates a variety of regulatory effects on a broad 
range of proteins [1-4]. These effects include facilitating membrane attachment of otherwise soluble 
proteins [3], regulating protein sorting to specific intracellular compartments [3], modulating protein 
folding and stability [2], and affecting the lateral distribution of proteins in membranes [3]. These S-
acylation-dependent processes impact key physiological molecules such as G protein-coupled 
receptors, heterotrimeric G proteins, ion channels and membrane receptors [5]. As a result, S-
acylation is essential for normal cellular physiology, and there is growing evidence linking 
dysfunctional S-acylation to specific disease processes [6]. The enzymes that regulate S-acylation 
dynamics are therefore receiving increasing interest as potential new drug targets. 
 
S-acylation enzymes 
 Nearly all S-acylation reactions in eukaryotic cells are mediated by enzymes defined by the 
presence of a conserved 51 amino acid zinc finger domain containing a central aspartate-histidine-
histidine-cysteine (DHHC) tetrapeptide [7-12]. ,QPDPPDOVWKHVH³]'++&´HQ]\PHVare encoded by 
more than twenty distinct genes [13]. The process of zDHHC-catalysed S-acylation has been shown to 
occur in two steps: attachment of the acyl group to the zDHHC enzyme (autoacylation), followed by 
transfer of this acyl chain to a specific cysteine in the substrate protein [14, 15]. The importance of the 
cysteine within the conserved DHHC tetrapeptide for catalysis has been demonstrated in numerous 
studies, where its mutation has resulted in a loss of both autoacylation and substrate S-acylation [9]. 
All zDHHC enzyme isoforms are thought to share a similar membrane topology, having 4-6 
membrane-spanning domains and with the catalytic DHHC-cysteine-rich domain present on a 
cytoplasmic loop [9, 16]. As zDHHC enzymes are membrane associated, the process of S-acylation 
can only occur at the cytosolic face of intracellular membranes. This distinguishes S-acylation from 
other types of lipidation events, such as myristoylation and prenylation, which are catalysed in the cell 
cytosol [17]. 
 Although the vast majority of S-acylation reactions occurring in cells appear to be catalyzed 
by zDHHC enzymes [18], the process of protein deacylation is less well understood. Such dynamic 
regulation of S-acylation is essential for the function of many proteins, including signalling molecules 
such as RAS [19]. The cytosolic thioesterases enzymes APT1 and APT2 (acyl protein thioesterase) 
are generally thought to be responsible for deacylation reactions, and indeed APT1 has been shown to 
modulate RAS -acylation dynamics [20]. However it is likely that there are many other thioesterases 
enzymes that contribute to protein deacylation and which remain to be fully characterised. 
 
zDHHC Localisation 
 The first comprehensive study of mammalian zDHHC enzyme localisation was undertaken by 
Ohno et al [21]. In this study, the distribution of zDHHC enzymes with an N-terminal His6-Myc or 
FLAG tag was examined in transfected HEK293T cells. It was clear from this study that the majority 
of human zDHHC enzymes localise to the endoplasmic reticulum (ER) and the Golgi apparatus, with 
a small number detected at the plasma membrane. This study serves as an important reference point 
for interested researchers. However, some of the zDHHC enzymes examined by Ohno et al have been 
reported to have different localisations in other studies; this might reflect cell-type specific differences 
(e.g. in expression of specific accessory factors) or might be due to the generally high expression 
levels of transfected proteins in HEK293T cells, which could affect trafficking/folding of certain 
zDHHC enzymes. Some examples include zDHHC4, which was reported to be localised to the Golgi 
in HEK293T cells but which was subsequently identified at the endoplasmic reticulum in 
hippocampal neurons [22], PC12 cells [23] and indeed HEK293T cells [23]. zDHHC2 was described 
as an ER/Golgi protein by Ohno et al, however other studies showed localisation of zDHHC2 to the 
plasma membrane and recycling endosomes in PC12 cells [24], HEK293 cells [24] and hippocampal 
neurons [25]. It will be important in future work to verify the localisations of all endogenously-
expressed zDHHC enzymes by antibody staining. Thus far this has only been achieved for a small 
number of the enzymes, e.g. [26], mainly reflecting an absence of suitable and specific antibodies 
against zDHHC enzymes. There are seven zDHHC genes in the yeast Saccharomyces cerevisiae, and 
the resulting proteins have been reported to localise in an isoform-specific manner on the ER, Golgi, 
plasma membrane or vacuole [8, 21, 27-29]. 
 Existing knowledge about the targeting signals within zDHHC enzymes that mediate their 
intracellular targeting is somewhat limited. zDHHC4 and zDHHC6 utilise C-terminal lysine-based 
signals to allow ER retention [23]. Mutational analysis identified a KKXX motif in zDHHC6 and a 
KXX motif in zDHHC4 that are important for ER retention; these signals occur at the extreme C-
termini of the zDHHC enzymes [23]. Removing the KXX motif from zDHHC4 led to its 
redistribution onto Golgi membranes, whereas zDHHC6 moved towards the plasma membrane and a 
perinuclear Golgi-like compartment. Furthermore, the lysine signals from both zDHHC4 and 
zDHHC6 were sufficient to relocalise zDHHC3 from the Golgi to the ER when they were appended 
to the C-terminus of this protein. Although these studies provide key information on how the 
localisations of zDHHC4/6 are achieved, other ER-localised zDHHC enzymes do not contain obvious 
lysine-based sorting signals, implying that these other isoforms use distinct signals to become 
localised to the ER. These localisation signals might be contained within the transmembrane domains, 
or involve cytoplasmic signals, such as arginine-based motifs [30]. 
 In PC12 cells and neurons, zDHHC2 exhibits a dynamic localisation, being present on mobile 
vesicles that traffic between recycling endosomes and the plasma membrane [24, 25, 31]. This 
dynamic cycling of zDHHC2 is proposed to require the cytoplasmic C-terminus of this enzyme [24] 
and is important functionally for controlling activity-dependent S-acylation and synaptic clustering of 
PSD95 [31]. 
 
zDHHC Substrate Specificity 
 A major outstanding question in the protein S-acylation field relates to the specificity of 
interaction between zDHHC enzymes and substrate proteins. Numerous S-acylation assays where S-
acyl-transferases and potential substrates were co-expressed in the same cell reveal various degrees of 
selectivity/promiscuity for both zDHHC enzymes and substrates [11]. Kinetics of membrane 
localization/ S-acylation between stereoisomeric semisynthetic NRas peptides have suggested that 
zDHHC enzymes do not recognize the surrounding to the S-acylated cysteine(s) residues on substrates 
[32]. Therefore, zDHHC enzymes that exhibit selective interactions must recognise regions on 
substrates that are distal to the S-acylated cysteine(s). Indeed, the yeast Pfa3 recognises a region 
downstream of the palmitoylated SH4 domain of Vac8 [33], whereas zDHHC17 recognises a 
hydrophobic region downstream of the cysteine-rich domain of SNAP25 [34], as well as a region 
outside the palmitoylated cISTID domain of NMNAT2 [35]. zDHHC-substrate interactions seem to 
be mediated by particular modules found on certain zDHHC enzymes: zDHHC5 and zDHHC8 
recognise GRIP1b via their C-terminal PDZ ligands and simultaneous depletion of these enzymes 
almost abolishes GRIP1 S-acylation [36];  zDHHC17 binds to huntingtin (HTT) via its N-terminal 
ankyrin-repeat (ANK) domain, and RNAi-mediated depletion of this enzyme reduced HTT S-
acylation [37]. Furthermore, appending the ankyrin-repeats from zDHHC17 onto zDHHC3, enabled 
the latter enzyme to S-acylate huntingtin [37]. Recently, the ANK domain of zDHHC17 was also 
shown to recruit CSP and SNAP25, and its deletion rendered zDHHC17 unable to S-acylate these two 
substrates [38]. The above indicate that PDZ-binding and ANK modules are indeed substrate-
recruiting regions of zDHHCs; nevertheless, PDZ or ANK mediated interactions do not seem to 
always result in substrate S-acylation, and this has been observed for PSD95 recruitment by 
]'++&¶V3'=LQWHUaction motif [39]DQGDOVRIRU61$3&63UHFUXLWPHQWE\]'++&¶V$NK 
domain [38]. It would be interesting to see whether the predicted PDZ binding motifs on zDHHC3, 14 
and 23 also bind PDZ-containing proteins, and whether these interactions result in substrate S-
acylation.  
The notion that the above zDHHC enzymes exhibit specific substrate profiles is also 
supported by the clear phenotypes of respective zDHHC mutant mice. zDHHC8 knockout mice have 
deficits in pre-pulse inhibition (PPI) and exploratory behaviour and underlying changes in synapse 
formation and dendritic growth [40]. zDHHC17 genetrap mice exhibit motor coordination deficits and 
decreased PPI, and display a decreased volume of striatum, cerebral cortex and hippocampus, 
decreased density of medium spiny neurons, and a decreased number of excitatory synapses [41]. 
zDHHC17 mice also have a deficit in hippocampal-dependent learning and exhibit motor 
abnormalities [42]. Collectively, these phenotypes show that individual zDHHC enzymes have 
important physiological functions, although it will be important in follow-up work to test whether 
these changes specifically reflect a loss of S-acylation activity or are related to other functions of these 
enzymes; such S-acyl-transferase-independent functions have been demonstrated for zDHHC17 [43] 
and the yeast zDHHC enzymes Swf1 [44] and Akr1 [45]. 
Certain zDHHC enzymes (such as the Golgi-localised zDHHC3 and zDHHC7) do not seem 
to be very selective in the substrates that they can acylate, which is reflected from the fact that these 
commonly appear as highly active against a plethora of proteins, upon co-expression within the same 
cell.  Indeed, zDHHC3 and zDHHC7 do not seem to recognise their apparent substrates 
(CSP/SNAP25), but are able to S-acylate them more robustly upon co-expression, compared to (the 
also Golgi-localized) zDHHC17 and zDHHC13 [38]. Similarly, zDHHC7 could S-acylate NMNAT2 
more robustly than zDHHC17, despite the fact that only the latter, but not the former, could bind to 
NMNAT2 lacking its palmitoylated cISTID domain [35]Hence, at least within the Golgi region, 
where most S-acylation events tend to occur [32], two classes of zDHHC enzymes seem to exist: a 
class with low substrate affinity but very high S-acyl-transferase activity (zDHHC3/zDHHC7), and 
another one with high substrate affinity but low S-acyl-transferase activity (zDHHC17/zDHHC13); 
the first class may exist to facilitate S-acylation of multiple substrates which are already weakly 
attached to membranes (due to either intrinsic affinity, or myristoylation/ prenylation), while the 
second class ensures substrate-specific S-acylation of proteins with no, or very weak membrane 
affinity; the latter are recruited for S-acylation by specific modules within certain zDHHC enzymes. 
 
Diseases Associated with S-acylation Deficits 
 There is strong evidence linking S-acylation by zDHHC9 with intellectual disability (ID). One 
study identified mutations in ZDHHC9 as the cause of ID in 4 out of 250 families studied [46], and 
importantly, two of these mutations resulted in single amino acid changes in the DHHC-CR domain 
(R148W and P150S). These amino substitutions have since been shown to affect the auto-acylation of 
zDHHC9, albeit in different ways [47]. Although it is possible that these mutations cause ID by 
affecting other functions of zDHHC9, it is most likely that deficits in autoacylation and subsequent 
substrate S-acylation are responsible for this disorder in the individuals with ZDHHC9 mutations. Key 
substrates of zDHHC9 are thought to be the S-acylated RAS isoforms (H- and N-RAS) [48], and 
knockdown of this enzyme reportedly results in mis-localisation of H-RAS in neurons [49]. 
Importantly, mutations in RAS proteins are associated with a range of disorders many of which have 
ID as a feature [46], suggesting that loss of RAS S-acylation could be a contributing factor leading to 
ID in the affected individuals. Clearly an important area of research will be to map the substrates of 
zDHHC9, which could be achieved by employing quantitative proteomics on wild-type and knockout 
mouse models or following RNA-mediated knockdown of zDHHC9 in cultured cells. 
 Mutations in the enzymes that mediate deacylation of proteins are also known to cause 
disease. Removal of acyl chains from S-acylated proteins is mediated by thioesterase enzymes with a 
characteristic D/E-hydrolase fold [50]; of these, the cytosolic enzymes APT1 and APT2 are thought to 
be responsible for S-acylation/deacylation turnover of numerous proteins. A related protein, PPT1 
(protein palmitoyl thioesterase 1) is localised to lysosomes, where it functions in the deacylation of 
proteins during their degradation [51-53]. Mutations in PPT1 are known to cause infantile neuronal 
ceroid lipofuscinosis (INCL) [54] an early-onset neurodegenerative disorder, characterised by 
blindness, seizures, and cognitive and motor deficits [55]. Symptoms of INCL typically appear around 
18 months of age and are followed by death in early childhood; there is currently no cure for this 
disorder. 
 There is also evidence that mutations that disrupt the S-acylation of specific 
substrates can lead to neuronal dysfunction. Of interest, recent work identified mutations in the 
DNAJC5 gene, encoding cysteine-string protein (CSP), as the cause of adult-onset NCL (ANCL) in 
several unrelated families [56-58]. Two disease-causing mutations were identified that resulted in a 
Leucine-to-Arginine substitution of amino acid 115 (L115R) or a deletion of the neighbouring 
cysteine residue ('L116). These mutations occur in a region of the CSP protein that is highly S-
acylated [59] and were shown to lead to a loss of S-acylated monomers of CSP (on SDS gels) and the 
presence of high molecular weight SDS-resistant aggregates [60]. Formation of these aggregates was 
promoted by co-expression of zDHHC enzymes that are active against CSP (zDHHC-3, -7 and -17) 
but not by inactive forms of these enzymes [60]. Furthermore, the aggregates were solubilised by 
hydroxylamine, a chemical which deacylates proteins [60]. This work suggested that the aggregation 
of ANCL mutants is promoted by their S-acylation and also that the aggregates are stabilised by this 
modification. Recent work has shown that the mutants (particularly L115R) can form aggregates in 
the absence of S-acylation [61]. It was also suggested that hydroxylamine treatment did not solubilise 
the aggregates, although the experimental conditions employed in this study did not lead to efficient 
deacylation of wild-type CSP, questioning this conclusion [61]. Irrespective of these differences it is 
clear that enhanced aggregation of CSP mutants might be a key feature of ANCL perhaps leading to 
disruption of protein degradation pathways. 
In addition to these clear examples of where defects in S-acylation cause disease, there are a 
number of other suggested links between zDHHC enzymes and disease: (i) a ZDHHC8 SNP and 
schizophrenia [62], which has not been consistently seen in different studies; (ii) reduction of 
zDHHC17 activity KDVEHHQSURSRVHGDVDSRVVLEOHFRQWULEXWLQJIDFWRUWR+XQWLQJWRQ¶VGLVHDVH [6, 41, 
63], although as yet there is no clinical evidence to support this idea; and (iii) expression changes in 
zDHHC2, zDHHC9, zDHHC11 and zDHHC14 have been reported in different cancers [64]. 
 
Perspective 
 The identification of the zDHHC enzyme family was a major breakthrough for the S-acylation 
field, and recent evidence is revealing the importance of these enzymes for physiology and pathology. 
Continued progress is this area is likely to come from the further characterisation of mechanisms 
underlying zDHHC-substrate specificity, profiling of the substrates of individual zDHHC enzymes, 
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